TABLE OF CONTENTS
|  |  |  | Volume 2, January 2012 |  | In this issue
Original Articles
| |  |  | | Advertisement |  | British Journal of Cancer presents: Web Focus on MicroRNA
MicroRNAs have emerged as major new mechanisms of regulation of gene function, potential therapeutic targets, with roles in diagnosis, prognosis and biomarkers.
This collection puts MicroRNA in context of other molecular classifications and then investigative articles and reviews cover the main tumour types where microRNAs are emerging as having important roles in biological processes including lung cancer, AML, melanoma, colorectal cancer, nasopharyngeal carcinoma, bladder cancer, rhabdomyosarcoma and heptacellular carcinoma.
Read the articles for FREE |
|  | | | Original Articles | Top |  | Inhibition of cell cycle progression by dual phosphatidylinositol-3-kinase and mTOR blockade in cyclin D2 positive multiple myeloma bearing IgH translocationsJ Glassford, D Kassen, J Quinn, C Stengel, K Kallinikou, A Khwaja and K L Yong Blood Cancer J 2012 2: e50; 10.1038/bcj.2011.44 Abstract | Full Text |  |  |  | Drug-mediated inhibition of Fli-1 for the treatment of leukemiaY-J Li, X Zhao, L M Vecchiarelli-Federico, Y Li, A Datti, Y Cheng and Y Ben-David Blood Cancer J 2012 2: e54; 10.1038/bcj.2011.52 Abstract | Full Text |  |  |  | Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutationsM Neumann, S Heesch, N Gökbuget, S Schwartz, C Schlee, O Benlasfer, N Farhadi-Sartangi, J Thibaut, T Burmeister, D Hoelzer, W-K Hofmann, E Thiel and C D Baldus Blood Cancer J 2012 2: e55; 10.1038/bcj.2011.49 Abstract | Full Text |  |  |  | Elevated calpain activity in acute myelogenous leukemia correlates with decreased calpastatin expressionM Niapour, C Farr, M Minden and S A Berger Blood Cancer J 2012 2: e51; 10.1038/bcj.2011.50 Abstract | Full Text |  |  |  | The relationship between cardiac and liver iron evaluated by MR imaging in haematological malignancies and chronic liver diseaseJ M Virtanen, K J Remes, M A Itälä-Remes, J P Saunavaara, M E Komu, A M Partanen and R K Parkkola Blood Cancer J 2012 2: e49; 10.1038/bcj.2011.48 Abstract | Full Text |  |  |  | Entourage: the immune microenvironment following follicular lymphomaB E Wahlin, B Sander, B Christensson, B Østenstad, H Holte, P D Brown, C Sundström and E Kimby Blood Cancer J 2012 2: e52; 10.1038/bcj.2011.53 Abstract | Full Text |  |  |  | Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disordersS Yoshizawa, J H Ohyashiki, M Ohyashiki, T Umezu, K Suzuki, A Inagaki, S Iida and K Ohyashiki Blood Cancer J 2012 2: e53; 10.1038/bcj.2011.51 Abstract | Full Text |  |  |  | | Advertisement |  | |
|  | | | You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
|
No comments:
Post a Comment